Moderna Aktie
WKN DE: A2N9D9 / ISIN: US60770K1079
|
20.11.2026 09:55:00
|
Moderna vs. BioNTech: Why Only 1 Is a Buy Heading Into 2027
The coronavirus pandemic turned two little-known mRNA companies into household names. Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) brought their vaccines to market, collected billions of dollars in revenue, and then watched demand fade in recent years. Both stocks fell significantly from their highs, and both companies have spent the past few years trying to prove they're more than coronavirus vaccine makers.
This year, their paths have diverged. Moderna's stock has soared as investors rushed to bet on the company's promising personalized cancer vaccine program. BioNTech, meanwhile, saw its stock price slip and prepared to say goodbye to its founders.
So, heading into 2027, which of these mRNA pioneers is the better buy?
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Inc
|
18.11.26 |
Aufschläge in New York: Zum Handelsende Pluszeichen im NASDAQ 100 (finanzen.at) | |
|
18.11.26 |
NASDAQ-Handel: NASDAQ 100 zeigt sich am Nachmittag fester (finanzen.at) | |
|
17.11.26 |
NASDAQ 100-Handel aktuell: NASDAQ 100 am Dienstagnachmittag in Rot (finanzen.at) | |
|
17.11.26 |
Gute Stimmung in New York: NASDAQ 100 zum Start des Dienstagshandels fester (finanzen.at) | |
|
12.11.26 |
S&P 500-Handel aktuell: S&P 500 verbucht schlussendlich Verluste (finanzen.at) | |
|
12.11.26 |
Anleger in New York halten sich zurück: NASDAQ 100 fällt zum Handelsende zurück (finanzen.at) | |
|
11.11.26 |
Freundlicher Handel in New York: NASDAQ 100 stärker (finanzen.at) | |
|
11.11.26 |
Pluszeichen in New York: NASDAQ 100 klettert (finanzen.at) |
Analysen zu Moderna Inc
| 12.05.26 | Moderna Hold | Jefferies & Company Inc. |
Aktien in diesem Artikel
| BioNTech (ADRs) | 73,40 | -0,94% |
|
| Moderna Inc | 179,72 | -1,08% |
|